Metabolic kinetics of p-aminobenzoic acid in rabbits

Dah Jing Song, Yih Ho, Kuang Yang Hsu

研究成果: 雜誌貢獻文章

3 引文 (Scopus)

摘要

The metabolic kinetics of p-aminobenzoic acid (PABA) in rabbits was studied. PABA is predominantly metabolized by acetylation and glycine conjugation to form p-acetamidobenzoic acid (PAABA), p-aminohippuric acid (PAHA), and p-acetamidohippuric acid (PAAHA). After PABA IV administration (20 mg/kg) to rapid (n = 16) and slow (n = 8) acetylation rabbits, PABA was eliminated rapidly. The half-lives of PABA were 7.01 ± 0.32 min in rapid acetylation rabbits and 7.08 ± 0.78 min in slow acetylation rabbits. Significant differences were obtained in formation of PAABA and PAHA formed from PABA in both acetylation phenotype rabbits. The formation fraction of PAABA, formed by acetylation of PABA, was 0.8029 ± 0.0267 in rapid acetylators and 0.2385 ± 0.0428 in slow acetylators (p <0.001). PAHA formed from PABA was 0.0462 ± 0.0102 in rapid acetylators and 0.6652 ± 0.0562 in slow acetylators (p <0.001). Only 0.0156 ± 0.0030 of PABA could be detected as PAAHA in rapid acetylation rabbits which was obtained by acetylation of PAHA. After individual IV injection of PAHA, PAAHA, and PAABA to both phenotypes of rabbits, PAABA and PAAHA were eliminated in their unchanged forms whereas PAHA was further acetylated to form PAAHA. The formation fraction of PAAHA formed from the acetylation of PAHA was 0.4408 ± 0.0570 in rapid acetylators and 0.0539 ± 0.0084 in slow acetylators (p = 0.002). From the results obtained, metabolic pathways of PABA show significant differences in both acetylation phenotypes of rabbits. Acetylation is the major metabolic route of PABA in rapid acetylation rabbits, while glycine conjugation is more predominant in slow acetylation rabbits.

原文英語
頁(從 - 到)263-270
頁數8
期刊Biopharmaceutics and Drug Disposition
20
發行號5
DOIs
出版狀態已發佈 - 1999

指紋

4-Aminobenzoic Acid
Acetylation
p-Aminohippuric Acid
Rabbits
Acids
Phenotype
Glycine
Metabolic Networks and Pathways

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

引用此文

Metabolic kinetics of p-aminobenzoic acid in rabbits. / Song, Dah Jing; Ho, Yih; Hsu, Kuang Yang.

於: Biopharmaceutics and Drug Disposition, 卷 20, 編號 5, 1999, p. 263-270.

研究成果: 雜誌貢獻文章

Song, Dah Jing ; Ho, Yih ; Hsu, Kuang Yang. / Metabolic kinetics of p-aminobenzoic acid in rabbits. 於: Biopharmaceutics and Drug Disposition. 1999 ; 卷 20, 編號 5. 頁 263-270.
@article{4ee2e374ffcb47b1a27697db0a811191,
title = "Metabolic kinetics of p-aminobenzoic acid in rabbits",
abstract = "The metabolic kinetics of p-aminobenzoic acid (PABA) in rabbits was studied. PABA is predominantly metabolized by acetylation and glycine conjugation to form p-acetamidobenzoic acid (PAABA), p-aminohippuric acid (PAHA), and p-acetamidohippuric acid (PAAHA). After PABA IV administration (20 mg/kg) to rapid (n = 16) and slow (n = 8) acetylation rabbits, PABA was eliminated rapidly. The half-lives of PABA were 7.01 ± 0.32 min in rapid acetylation rabbits and 7.08 ± 0.78 min in slow acetylation rabbits. Significant differences were obtained in formation of PAABA and PAHA formed from PABA in both acetylation phenotype rabbits. The formation fraction of PAABA, formed by acetylation of PABA, was 0.8029 ± 0.0267 in rapid acetylators and 0.2385 ± 0.0428 in slow acetylators (p <0.001). PAHA formed from PABA was 0.0462 ± 0.0102 in rapid acetylators and 0.6652 ± 0.0562 in slow acetylators (p <0.001). Only 0.0156 ± 0.0030 of PABA could be detected as PAAHA in rapid acetylation rabbits which was obtained by acetylation of PAHA. After individual IV injection of PAHA, PAAHA, and PAABA to both phenotypes of rabbits, PAABA and PAAHA were eliminated in their unchanged forms whereas PAHA was further acetylated to form PAAHA. The formation fraction of PAAHA formed from the acetylation of PAHA was 0.4408 ± 0.0570 in rapid acetylators and 0.0539 ± 0.0084 in slow acetylators (p = 0.002). From the results obtained, metabolic pathways of PABA show significant differences in both acetylation phenotypes of rabbits. Acetylation is the major metabolic route of PABA in rapid acetylation rabbits, while glycine conjugation is more predominant in slow acetylation rabbits.",
keywords = "Metabolic kinetics, Metabolites, p-aminobenzoic acid",
author = "Song, {Dah Jing} and Yih Ho and Hsu, {Kuang Yang}",
year = "1999",
doi = "10.1002/(SICI)1099-081X(199907)20:5<263::AID-BDD184>3.0.CO;2-G",
language = "English",
volume = "20",
pages = "263--270",
journal = "Biopharmaceutics and Drug Disposition",
issn = "0142-2782",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - Metabolic kinetics of p-aminobenzoic acid in rabbits

AU - Song, Dah Jing

AU - Ho, Yih

AU - Hsu, Kuang Yang

PY - 1999

Y1 - 1999

N2 - The metabolic kinetics of p-aminobenzoic acid (PABA) in rabbits was studied. PABA is predominantly metabolized by acetylation and glycine conjugation to form p-acetamidobenzoic acid (PAABA), p-aminohippuric acid (PAHA), and p-acetamidohippuric acid (PAAHA). After PABA IV administration (20 mg/kg) to rapid (n = 16) and slow (n = 8) acetylation rabbits, PABA was eliminated rapidly. The half-lives of PABA were 7.01 ± 0.32 min in rapid acetylation rabbits and 7.08 ± 0.78 min in slow acetylation rabbits. Significant differences were obtained in formation of PAABA and PAHA formed from PABA in both acetylation phenotype rabbits. The formation fraction of PAABA, formed by acetylation of PABA, was 0.8029 ± 0.0267 in rapid acetylators and 0.2385 ± 0.0428 in slow acetylators (p <0.001). PAHA formed from PABA was 0.0462 ± 0.0102 in rapid acetylators and 0.6652 ± 0.0562 in slow acetylators (p <0.001). Only 0.0156 ± 0.0030 of PABA could be detected as PAAHA in rapid acetylation rabbits which was obtained by acetylation of PAHA. After individual IV injection of PAHA, PAAHA, and PAABA to both phenotypes of rabbits, PAABA and PAAHA were eliminated in their unchanged forms whereas PAHA was further acetylated to form PAAHA. The formation fraction of PAAHA formed from the acetylation of PAHA was 0.4408 ± 0.0570 in rapid acetylators and 0.0539 ± 0.0084 in slow acetylators (p = 0.002). From the results obtained, metabolic pathways of PABA show significant differences in both acetylation phenotypes of rabbits. Acetylation is the major metabolic route of PABA in rapid acetylation rabbits, while glycine conjugation is more predominant in slow acetylation rabbits.

AB - The metabolic kinetics of p-aminobenzoic acid (PABA) in rabbits was studied. PABA is predominantly metabolized by acetylation and glycine conjugation to form p-acetamidobenzoic acid (PAABA), p-aminohippuric acid (PAHA), and p-acetamidohippuric acid (PAAHA). After PABA IV administration (20 mg/kg) to rapid (n = 16) and slow (n = 8) acetylation rabbits, PABA was eliminated rapidly. The half-lives of PABA were 7.01 ± 0.32 min in rapid acetylation rabbits and 7.08 ± 0.78 min in slow acetylation rabbits. Significant differences were obtained in formation of PAABA and PAHA formed from PABA in both acetylation phenotype rabbits. The formation fraction of PAABA, formed by acetylation of PABA, was 0.8029 ± 0.0267 in rapid acetylators and 0.2385 ± 0.0428 in slow acetylators (p <0.001). PAHA formed from PABA was 0.0462 ± 0.0102 in rapid acetylators and 0.6652 ± 0.0562 in slow acetylators (p <0.001). Only 0.0156 ± 0.0030 of PABA could be detected as PAAHA in rapid acetylation rabbits which was obtained by acetylation of PAHA. After individual IV injection of PAHA, PAAHA, and PAABA to both phenotypes of rabbits, PAABA and PAAHA were eliminated in their unchanged forms whereas PAHA was further acetylated to form PAAHA. The formation fraction of PAAHA formed from the acetylation of PAHA was 0.4408 ± 0.0570 in rapid acetylators and 0.0539 ± 0.0084 in slow acetylators (p = 0.002). From the results obtained, metabolic pathways of PABA show significant differences in both acetylation phenotypes of rabbits. Acetylation is the major metabolic route of PABA in rapid acetylation rabbits, while glycine conjugation is more predominant in slow acetylation rabbits.

KW - Metabolic kinetics

KW - Metabolites

KW - p-aminobenzoic acid

UR - http://www.scopus.com/inward/record.url?scp=0033381252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033381252&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1099-081X(199907)20:5<263::AID-BDD184>3.0.CO;2-G

DO - 10.1002/(SICI)1099-081X(199907)20:5<263::AID-BDD184>3.0.CO;2-G

M3 - Article

C2 - 10594871

AN - SCOPUS:0033381252

VL - 20

SP - 263

EP - 270

JO - Biopharmaceutics and Drug Disposition

JF - Biopharmaceutics and Drug Disposition

SN - 0142-2782

IS - 5

ER -